Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study

Journal of Neurotrauma

Volumn 33, Issue 13, 2016, Pages 1270-1277

  Wang, Kevin K W ^a   Yang, Zhihui ^a   Yue, John K ^b,c   Zhang, Zhiqun ^a   Winkler, Ethan A ^b,c   Puccio, Ava M ^d   Diaz Arrastia, Ramon ^e   Lingsma, Hester F ^f   Yuh, Esther L ^b,c   Mukherjee, Pratik ^b,c   Valadka, Alex B ^g   Gordon, Wayne A ^h   Okonkwo, David O ^d   Manley, Geoffrey T ^b,c   Cooper, Shelly R ^b,c,f   Dams O'Connor, Kristen ^h   Hricik, Allison J ^d   Inoue, Tomoo ^b,c   Maas, Andrew I R ⁱ   Menon, David K ^j   Schnyer, David M ^k   Sinha, Tuhin K ^c   Vassar, Mary J ^b,c   more..

^a UNIVERSITY OF FLORIDA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g Seton Brain and Spine Institute   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k UNIVERSITY OF TEXAS AT AUSTIN   (United States)

more..

Author keywords

autoantibody; autoimmunity; biomarkers; glia; traumatic brain injury

Indexed keywords

AUTOANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PILOT STUDY; TRAUMATIC BRAIN INJURY; ACUTE DISEASE; ADOLESCENT; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BRAIN INJURIES, TRAUMATIC; CHRONIC DISEASE; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; YOUNG ADULT;

EID: 84975678771     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2015.3881     Document Type: Article

References (56)

1. Hergenroeder, G.W., Redell, J.B., Moore, A.N., and Dash, P.K. (2008). Biomarkers in the clinical diagnosis and management of traumatic brain injury. Mol. Diagn. Ther. 12, 345-358.
2. Zhang, Z., Mondello, S., Kobeissy, F., Rubenstein, R., Streeter, J., Hayes, R.L., and Wang, K.K. (2011). Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside. Transl. Stroke Res. 2, 455-462.
3. Yang, Z., and Wang, K.K. (2015) Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarkers. Trends Neurosci. 38, 364-374.
4. Agoston, D.V., and Elsayed, M.M. (2012). Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder. Front. Neurol. 3, 107.
5. Liu, M.C., Akinyi, L., Scharf, D., Mo, J., Larner, S.F., Muller, U., Oli, M.W., Zheng, W., Kobeissy, F., Papa, L., Lu, X.C., Dave, J.R., Tortella, F.C., Hayes, R.L., and Wang, K.K.W. (2010). Ubiquitin Cterminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur. J. Neurosci. 31, 722-732.
6. Dambinova, S.A., Khounteev, G.A., Izykenova, G.A., Zavolokov, I.G., Ilyukhina, A.Y., and Skoromets, A.A. (2003). Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem. 49, 1752-1762.
7. Colasanti, T., Barbati, C., Rosano, G., Malorni, W., and Ortona, E. (2010). Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression. Autoimmun. Rev. 9, 807-811.
8. D'Andrea, M.R. (2005). Add Alzheimer's disease to the list of autoimmune diseases. Med. Hypotheses 64, 458-463.
9. Ankeny, D.P., Lucin, K.M., Sanders, V.M., McGaughy, V.M., and Popovich, P.G. (2006). Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J. Neurochem. 99, 1073-1087.
10. Popovich, P.G., Stokes, B.T., and Whitacre, C.C. (1996). Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J. Neurosci. Res. 45, 349-363.
11. Lancaster, E., and Dalmau, J. (2012). Neuronal autoantigens- pathogenesis, associated disorders and antibody testing. Nat. Rev. Neurol. 8, 380-390.
12. Svetlov, S.I., Prima, V., Kirk, D.R., Gutierrez, H., Curley, K.C., Hayes, R.L., and Wang, K.K. (2010). Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure. J. Trauma 69, 795-804.
13. Ponomarenko, N.A., Durova, O.M., Vorobiev, I.I., Belogurov, A.A., Telegin, G.B., Suchkov, S.V., Misikov, V.K., Morse, H.C., III, and Gabibov, A.G. (2006). Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale. Immunol. Lett. 103, 45-50.
14. Svetlov, S.I., Prima, V., Glushakova, O., Svetlov, A., Kirk, D.R., Gutierrez, H., Serebruany, V.L., Curley, K.C., Wang, K.K., and Hayes, R.L. (2012). Neuro-glial and systemic mechanisms of pathological responses in rat models of primary blast overpressure compared to ''composite'' blast. Front. Neurol. 3, 15.
15. Hedegaard, C.J., Chen, N., Sellebjerg, F., Sørensen, P.S., Leslie, R.G., Bendtzen, K., and Nielsen, C.H. (2009). Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: A role in regulating cytokine responses to MBP. Immunology 128, Suppl 1, e451-e461.
16. Cox, A.L., Coles, A.J., Nortje, J., Bradley, P.G., Chatfield, D.A., Thompson, S.J., and Menon, D.K. (2006). An investigation of autoreactivity after head injury. J. Neuroimmunol. 174, 180-186.
17. Sorokina, E.G., Semenova, Z.B., Granstrem, O.K., Karaseva, O.V., Meshcheriakov, S.V., Reutov, V.P., Sushkevich, G.N., Pinelis, V.G., and Roshal, L.M. (2010). [S100B protein and autoantibodies to S100B protein in diagnostics of brain damage in craniocerebral trauma in children]. (Rus) Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 110, 30-35.
18. Goryunova, A.V., Bazarnaya, N.A., Sorokina, E.G., Semenova, N.Y., Globa, O.V., Semenova, Z.B., Pinelis, V.G., Roshal, L.M., and Maslova, O.I. (2007). Glutamate receptor autoantibody concentrations in children with chronic post-traumatic headache. Neurosci. Behav. Physiol. 37, 761-764.
19. Siman, R., Toraskar, N., Dang, A., McNeil, E., McGarvey, M., Plaum, J., Maloney, E., and Grady, M.S. (2009). A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J. Neurotrauma 26, 1867-1877.
20. Tanriverdi, F., De Bellis, A., Bizzarro, A., Sinisi, A.A., Bellastella, G., Pane, E., Bellastella, A., Unluhizarci, K., Selcuklu, A., Casanueva, F.F., and Kelestimur, F. (2008). Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity Eur. J. Endocrinol. 159, 7-13.
21. Papa, L., Akinyi L, Liu MC, Pineda JA, Tepas JJ 3rd, Oli MW, Zheng W, Robinson G, Robicsek SA, Gabrielli A, Heaton SC, Hannay HJ, Demery JA, Brophy GM, Layon J, Robertson CS, Hayes RL, and Wang KK. (2010). Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit. Care Med. 38, 138-144.
22. Tanriverdi, F., De Bellis, A., Battaglia, M., Bellastella, G., Bizzarro, A., Sinisi, A.A., Bellastella, A., Unluhizarci, K., Selcuklu, A., Casanueva, F.F., and Kelestimur, F. (2010). Investigation of antihypothalamus and antipituitary antibodies in amateur boxers: is chronic repetitive head trauma-induced pituitary dysfunction associated with autoimmunity Eur. J. Endocrinol. 162, 861-867.
23. Brophy, G.M., Mondello, S., Papa, L., Robicsek, S.A., Gabrielli, A., Tepas, J., Buki, A., III, Robertson, C., Tortella, F.C., Hayes, R.L., and Wang, K.K. (2011). Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J. Neurotrauma 28, 861-870.
24. Zoltewicz, J.S., Mondello, S., Yang, B., Newsom, K.J., Kobeissy, F., Yao, C., Lu, X.C., Dave, J.R., Shear, D.A., Schmid, K., Rivera, V., Cram, T., Seaney, J., Zhang, Z., Wang, K.K., Hayes, R.L., and Tortella, F.C. (2013). Biomarkers track damage after graded injury severity in a rat model of penetrating brain injury. J. Neurotrauma 30, 1161-1169.
25. Marchi, N., Bazarian, J.J., Puvenna, V., Janigro, M., Ghosh, C., Zhong, J., Zhu, T., Blackman, E., Stewart, D., Ellis, J., Butler, R., and Janigro, D. (2013). Consequences of repeated blood-brain barrier disruption in football players. PLoS ONE 8, e56805.
26. Zhang, Z., Zoltewicz, J.S., Mondello, S., Newsom, K.J., Yang, Z., Yang, B., Kobeissy, F., Guingab, J., Glushakova, O., Robicsek, S., Heaton, S., Buki, A., Hannay, J., Gold, M.S., Rubenstein, R., Lu, X.C., Dave, J.R., Schmid, K., Tortella, F., Robertson, C.S., and Wang, K.K. (2014). Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products. PLoS ONE 9, e92698.
27. Giacoppo, S., Bramanti, P., Barresi, M., Celi, D., Foti Cuzzola, V., Palella, E., and Marino, S. (2012). Predictive biomarkers of recovery in traumatic brain injury. Neurocrit. Care 16, 470-477.
28. Yang, S.H., Gustafson, J., Gangidine, M., Stepien, D., Schuster, R., Pritts, T.A., Goodman, M.D., Remick, D.G., and Lentsch, A.B. (2013). A murine model of mild traumatic brain injury exhibiting cognitive and motor deficits. J. Surg. Res. 184, 981-988.
29. Yokobori, S., Hosein, K., Burks, S., Sharma, I., Gajavelli, S., and Bullock, R. (2013). Biomarkers for the clinical differential diagnosis in traumatic brain injury-a systematic review. CNS Neurosci. Ther. 19, 556-565.
30. Derfuss, T., and Meinl, E. (2012). Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment? Curr. Opin. Neurol. 25, 231-238.
31. Yue, J.K., Vassar, M.J., Lingsma, H.F., Cooper, S.R., Okonkwo, D.O., Valadka, A.B., Gordon, W.A., Maas, A.I., Mukherjee, P., Yuh, E.L., Puccio, A.M., Schnyer, D.M., and Manley, G.T.; TRACK-TBI Investigators. (2013). Transforming research and clinical knowledge in traumatic brain injury pilot: multicenter implementation of the common data elements for traumatic brain injury. J. Neurotrauma. 30, 1831-1844.
32. Manley, G.T., Diaz-Arrastia, R., Brophy, M., Engel, D., Goodman, C., Gwinn, K., Veenstra, T.D., Ling, G., Ottens, A.K., Tortella, F., and Hayes, R.L. (2010). Common Data Elements for Traumatic Brain Injury: Recommendations from the Biospecimens and Biomarkers Working Group. Arch. Phys. Med. Rehabil. 91, 1667-1672.
33. Mondello, S., Jeromin, A., Buki, A., Bullock, R., Czeiter, E., Kovacs,N., Barzo, P., Schmid, K., Tortella, F., Wang, K.K., and Hayes, R.L. (2012). Glial neuronal ratio: A novel index for differentiating injury type in patients with severe traumatic brain injury. J.Neurotrauma 29, 1096-1104.
34. Papa, L., Lewis, L.M., Falk, J.L., Zhang, Z., Silvestri, S., Giordano, P., Brophy, G.M., Demery, J.A., Dixit, N.K., Ferguson, I., Liu, M.C., Mo, J., Akinyi, L., Schmid, K., Mondello, S., Robertson, C.S., Tortella, F.C., Hayes, R.L., and Wang, K.K. (2012). Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann. Emerg. Med. 59, 471-483.
35. Papa, L., Lewis, L.M., Silvestri, S., Falk, J.L., Giordano, P., Brophy, G.M., Demery, J.A., Liu, M.C., Mo, J., Akinyi, L., Mondello, S., Schmid, K., Robertson, C.S., Tortella, F.C., Hayes, R.L., and Wang, K.K. (2012). Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J. Trauma Acute Care Surg. 72, 1335-1344.
36. Okonkwo, D.O., Yue, J.K., Puccio, A.M., Panczykowski, D.M., Inoue, T.,McMahon, P.J., Sorani,M.D.,Yuh,E.L., Lingsma, H.F.,Maas,A.I.R., Valadka, A.B., and Manley, G.T.; TRACK-TBI Investigators. (2013). GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study. J. Neurotrauma 30, 1490-1497.
37. Diaz-Arrastia, R., Wang, K.K. Papa, L., Sorani, M.D., Yue, J.K., Puccio, A.M., McMahon, P.J., Inoue, T., Yuh, E.L., Lingsma, H.F., Maas, A.I., Valadka, A.B., Okonkwo, D.O., and Manley, G.T.; TRACK-TBI Investigators. (2014). Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J. Neurotrauma 31, 19-25.
38. Kobeissy, F.H., Guingab-Cagmat, J.D., Razafsha, M., O'Steen, L., Zhang, Z., Hayes, R.L., Chiu, W.T., and Wang, K.K. (2011). Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research. PM R 3, Suppl, S139-S147.
39. Yang, Z., Lin, F., Robertson, C.S., and Wang, K.K. (2014). Dual vulnerability of TDP-43 to calpain and caspase-3 proteolysis after neurotoxic conditions and traumatic brain injury. J. Cereb. Blood Flow Metab. 34, 1444-1452.
40. Yuh, E.L., Cooper, S.R., Mukherjee, P., Yue, J.K., Lingsma, H.F., Gordon, W.A., Valadka, A.B., Okonkwo, D.O., Schnyer, D.M., Vassar, M.J., Maas, A.I., and Manley, G.T. (2014). Diffusion tensor imaging for outcome prediction in mild traumatic brain injury: A TRACK-TBI study. J. Neurotrauma. 31, 1457-1477.
41. Yue, J.K., Pronger, A.M., Ferguson, A.R., Temkin, N.R., Sharma, S., Rosand, J., Sorani, M.D., McAllister, T.W., Barber, J., Winkler, E.A., Burchard, E.G., Hu, D., Lingsma, H.F., Cooper, S.R., Puccio, A.M., Okonkwo, D.O., Diaz-Arrastia, R., and Manley, G.T.; COBRIT Investigators; TRACK-TBI Investigators. (2015). Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injury. Neurogenetics 16, 169-180.
42. Ratcliff, J.J., Adeoye, O., Lindsell, C.J., Hart, K.W., Pancioli, A., McMullan, J.T., Yue, J.K., Nishijima, D.K., Gordon, W.A., Valadka, A.B., Okonkwo, D.O., Lingsma, H.F., Maas, A.I., and Manley, G.T.; TRACK-TBI Investigators. (2014). ED disposition of the Glasgow Coma Scale 13 to 15 traumatic brain injury patient: Analysis of the Transforming Research and Clinical Knowledge in TBI study. Am. J. Emerg. Med. 32, 844-850.
43. Dams-O'Connor, K., Spielman, L., Singh, A., Gordon, W.A., Lingsma, H.F., Maas, A.I., Manley, G.T., Mukherjee, P., Okonkwo, D.O., Puccio, A.M., Schnyer, D.M., Valadka, A.B., Yue, J.K., and Yuh, E.L. (2013). The impact of previous traumatic brain injury on health and functioning: A TRACK-TBI study. 30, 2014-2020.
44. Herrmann, M., Jost, S., Kutz, S., Ebert, A.D., Kratz, T., Wunderlich, M.T., and Synowitz, H. (2000). Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J. Neurotrauma. 17, 113-122.
45. Raabe, A., Grolms, C., Keller, M., Döhnert, J., Sorge, O., and Seifert, V. (1998). Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir. (Wien) 140, 787-792.
46. Ruan, S., Noyes, K., and Bazarian, J.J. (2009). The economic impact of S-100B as a pre-head CT screening test on emergency department management of adult patients with mild traumatic brain injury. J. Neurotrauma. 26,1655-1664.
47. Rubenstein, R., Chang, B., Gray, P., Piltch, M., Bulgin, M.S., Sorensen-Melson, S., and Miller, M.W. (2010). A novel method for preclinical detection of PrPSc in blood. J. Gen. Virol. 91, 1883-1892.
48. Chang, B., Gray, P., Piltch, M., Bulgin, M.S., Sorensen-Melson, S., Miller, M.W., Davies, P., Brown, D.R., Coughlin, D.R., and Rubenstein, R. (2009). Surround optical fiber immunoassay (SOFIA): An ultrasensitive assay for prion protein detection. J. Virol. Methods 159, 15-22.
49. Watanabe, M., Uchida, K., Nakagaki, K., Trapnell, B.C., and Nakata, K. (2010). High avidity cytokine autoantibodies in health and disease: pathogenesis and mechanisms. Cytokine Growth Factor Rev. 21, 263-273.
50. Iseme, R.A., McEvoy, M., Kelly, B., Agnew, L., Attia, J., and Walker F.R. (2014) Autoantibodies and depression: evidence for a causal link? Neurosci. Biobehav. Rev. 40, 62-79.
51. Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI). Available at: http://tracktbi.ucsf.edu. Accessed: September 8, 2015.
52. TBI Endpoints Development (TED) Initiative. Available at: http:// tbiendpoints.ucsf.edu. Accessed: September 8, 2015.
53. de Olmos, J.S., Beltramino, C.A., and de Olmos de Lorenzo, S. (1994). Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol. Teratol. 16, 545-561.
54. Hall, E.D., Bryant, Y.D., Cho, W., and Sullivan, P.G. (2008). Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods. J. Neurotrauma. 25, 235-247.
55. Saltzman, J.W., Battaglino, R.A., Stott, H.L., and Morse, L.R. (2013). Rehabilitation considerations for traumatic brain injury in the geriatric population: epidemiology, neurobiology, prognosis, and management. Curr. Tran. Geriatr. Gerontol. Rep. 1, 149-158.
56. Smith, D.H., Johnson, V.E., and Stewart, W. (2013). Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat. Rev. Neurol. 9, 211-221.